NCT07914348
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07914348
Title Evaluation of LB-208 (HTR1B Antagonist) in Adult Patients With Relapsed or Refractory Solid Tumours and Lymphoma (SERONCO-1)
Acronym SERONCO-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Leukos Biotech S.L.
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.